Cetirizine (Generic Zyrtec) Ranitidine Cross-Contamination Lawsuit Lawyers

Consumers Across the United States Are Urged to Check Their Allergy Medication After a Nationwide Recall Raises Concerns About Contaminated Antihistamine Tablets and Potentially Serious Allergic Reactions.

What Parker Waichman LLP Found

• The FDA announced a nationwide recall involving certain lots of generic cetirizine (generic Zyrtec) tablets.
• The recall involves potential cross-contamination with ranitidine, a medication used to treat heartburn.
• Consumers with hypersensitivity to ranitidine ingredients may face serious or life-threatening reactions.
• The affected products were distributed nationwide in 100-tablet bottles with four identified lot numbers.
• Individuals injured by contaminated medications may have legal rights under product liability laws.

Millions of Americans rely on over-the-counter and prescription allergy medications every year to manage seasonal allergies, chronic hives, and other allergic conditions. Consumers expect these medications to contain only the ingredients listed on the label and to be manufactured under strict quality control standards. When contamination occurs during the manufacturing process, patients may unknowingly ingest medications containing unintended substances that could place their health at risk.

The U.S. Food and Drug Administration (FDA) recently announced a nationwide voluntary recall involving certain lots of cetirizine hydrochloride tablets USP 5 mg, a generic version of the widely recognized allergy medication Zyrtec. According to the recall notice, the affected medications may have been cross-contaminated with ranitidine, a drug historically used to treat heartburn and acid reflux.

Although no injuries had been reported at the time of the recall announcement, federal regulators warned that exposure to ingredients contained in ranitidine could cause severe and potentially life-threatening reactions in individuals who are hypersensitive to those ingredients. The FDA identified risks that include hypotension, difficulty breathing, difficulty swallowing, loss of consciousness, and other serious adverse reactions.

Medication recalls involving contamination are treated seriously because consumers have no practical way of identifying contaminated tablets before taking them. Patients trust that prescription and over-the-counter medications have been manufactured according to strict pharmaceutical quality standards. When contamination is discovered, immediate action is necessary to protect public health and prevent avoidable injuries.

For patients who suffered adverse reactions after taking contaminated medication, the recall may also raise important legal questions regarding pharmaceutical manufacturing practices, quality assurance procedures, and product liability.

Why Cross-Contamination in Medications Is a Serious Safety Issue

Every medication contains carefully measured active and inactive ingredients designed to produce a specific therapeutic effect. Pharmaceutical manufacturers are expected to follow rigorous manufacturing practices that prevent unintended substances from entering medications during production, packaging, labeling, and distribution.

Cross-contamination occurs when ingredients from one medication are inadvertently introduced into another product. This can happen if manufacturing equipment is not adequately cleaned between production runs, if quality control procedures fail, or if production systems allow different medications to come into contact with one another.

Even small amounts of contamination may present serious risks for certain patients. Individuals with allergies, sensitivities, or underlying medical conditions may experience unexpected reactions after exposure to ingredients that are not disclosed on the product label.

In this recall, the concern involves possible contamination of cetirizine tablets with ranitidine. Consumers purchasing an allergy medication would have no reason to expect the presence of a heartburn medication or any of its ingredients.

Medication contamination also undermines patient confidence in the pharmaceutical supply chain. Consumers rely on physicians, pharmacists, manufacturers, and regulators to ensure medications are accurately labeled and safe for their intended use. When contamination occurs, patients may unknowingly expose themselves to risks they never agreed to accept.

How the Potential Contamination Was Discovered

According to information released by the FDA, the contamination issue came to light after a pharmacy technician observed unusual abnormalities while counting and bottling cetirizine tablets.

The technician reportedly noticed what appeared to be a red dot on several tablets. Additional tablets showed discoloration that differed from the medication’s expected appearance. These visual abnormalities prompted further investigation into the affected products.

Observations made by pharmacists and pharmacy technicians frequently serve as an important layer of consumer protection. While pharmaceutical manufacturers maintain internal quality assurance programs, healthcare professionals often identify irregularities after products reach pharmacies and healthcare facilities.

Visual changes such as discoloration, unexpected markings, crumbling tablets, unusual odors, broken coatings, or inconsistent tablet shapes may indicate manufacturing defects or contamination. Although not every visual irregularity reflects a dangerous defect, any unexpected change in medication appearance deserves careful evaluation.

The prompt recognition of these abnormalities likely helped prevent additional potentially contaminated medication from reaching patients.

What Is Ranitidine and Why Could Cross-Contamination Be Dangerous?

Ranitidine was widely used for many years to reduce stomach acid and treat conditions such as heartburn, acid reflux, and ulcers. Although it was once one of the most commonly prescribed acid-reducing medications, concerns involving contamination in certain ranitidine products led to significant regulatory actions in recent years.

The current recall is not based on patients intentionally taking ranitidine. Instead, it involves the possibility that ingredients associated with ranitidine may have unintentionally contaminated cetirizine tablets during manufacturing.

According to the FDA, individuals who are hypersensitive to ingredients contained in ranitidine could experience serious adverse reactions, including:

• Hypotension (dangerously low blood pressure)
• Shortness of breath
• Difficulty swallowing
• Loss of consciousness
• Other potentially life-threatening allergic reactions

For many patients, allergic reactions can escalate rapidly. Severe hypersensitivity reactions may require emergency medical treatment, hospitalization, administration of epinephrine, respiratory support, or intensive monitoring.

Consumers taking allergy medication generally expect relief from allergic symptoms—not exposure to ingredients capable of triggering severe reactions.

Which Products Are Included in the Recall?

The recall involves:

Product

Cetirizine Hydrochloride Tablets USP 5 mg

Distributor

Rising Pharma Holdings Inc.

Package Size

100-tablet bottles

Expiration Date

October 2028

Affected Lot Numbers

• GY825029
• GY825030
• GY825031
• GY825032

The affected medications were distributed to retailers throughout the United States.

Consumers who possess any of these lot numbers should stop using the affected medication and follow the recall instructions provided by the manufacturer and the FDA.

Individuals uncertain whether their medication is included should compare the lot number printed on the bottle with the recalled lot numbers.

The Importance of Pharmaceutical Manufacturing Quality Control

Drug manufacturing requires extraordinary precision. Every stage of production must follow strict quality standards designed to prevent contamination, dosage errors, labeling mistakes, and other manufacturing failures.

Manufacturers generally employ multiple quality assurance measures, including:

• Equipment cleaning validation
• Batch testing
• Environmental monitoring
• Laboratory analysis
• Visual inspections
• Production documentation
• Employee training
• Packaging verification

When contamination occurs despite these safeguards, investigators often examine whether manufacturing procedures were properly followed or whether additional corrective actions should have been implemented.

Pharmaceutical recalls sometimes reveal broader concerns involving production practices, equipment maintenance, supplier controls, or quality management systems. Regulatory investigations may continue long after a recall announcement to determine the root cause of the contamination.

Consumers rely heavily on these quality control systems because medications cannot be independently inspected by patients before use.

Potential Injuries Associated With Contaminated Medications

Although no adverse events had been reported when the recall was announced, contaminated medications have the potential to cause significant health complications depending on the patient and the nature of the contamination.

Potential injuries may include:

• Severe allergic reactions
• Anaphylaxis
• Respiratory distress
• Low blood pressure
• Emergency room treatment
• Hospitalization
• Cardiovascular complications
• Loss of consciousness

Some patients face greater risks than others. Individuals with multiple allergies, compromised immune systems, chronic respiratory diseases, cardiovascular conditions, or previous medication sensitivities may be more vulnerable to adverse reactions.

Prompt medical evaluation is important whenever unexpected symptoms develop after taking recalled medication.

What Consumers Should Do If They Have Recalled Medication

Consumers who possess recalled cetirizine tablets should avoid taking additional doses from affected lots until they receive guidance from their pharmacist or healthcare provider.

Patients should:

• Check the lot number on the medication bottle.
• Determine whether it matches the recalled products.
• Follow manufacturer recall instructions.
• Contact their pharmacist if they have questions.
• Seek medical care immediately if unexpected symptoms develop.
• Preserve the medication bottle and packaging if an adverse reaction occurs.

Individuals who experience difficulty breathing, swelling, loss of consciousness, severe allergic reactions, or other emergency symptoms should seek immediate medical attention.

Cetirizine Injury Lawsuit FAQs

Can I file a lawsuit if I became ill after taking recalled cetirizine tablets?

Possibly. If you experienced a serious allergic reaction, required medical treatment, or suffered other injuries after taking recalled medication, you may have grounds to pursue a product liability claim. A legal evaluation can help determine whether the recalled medication contributed to your injuries.

What compensation may be available in a contaminated medication lawsuit?

Depending on the circumstances, compensation may include medical expenses, hospitalization costs, lost income, future medical care, pain and suffering, emotional distress, and other damages related to the injury.

Does a recall automatically mean the manufacturer is legally liable?

No. A recall does not automatically establish liability. However, a recall may serve as important evidence that a product presented a safety concern. Additional investigation is often necessary to determine how the contamination occurred and whether legal responsibility exists.

What evidence should I keep if I experienced a reaction?

Consumers should preserve the medication bottle, remaining tablets, pharmacy receipt, prescription records, medical records, photographs, and any documentation of treatment. These materials may become important evidence during a legal investigation.

What if I already finished the medication?

If you experienced unexpected symptoms while taking the recalled medication, you should discuss the situation with your healthcare provider. Pharmacy dispensing records may help determine whether your prescription came from one of the recalled lots.

How do product liability investigations involving contaminated drugs work?

These investigations often examine manufacturing records, quality assurance procedures, inspection reports, laboratory testing, distribution records, and medical evidence to determine whether contamination occurred and whether it caused a patient’s injuries.

How long do I have to file a lawsuit?

The filing deadline varies depending on state law and the specific facts of the case. Because legal deadlines can expire, individuals who believe they were harmed by a contaminated medication should have their situation evaluated as soon as possible.

Contact Parker Waichman LLP For A Free Case Review

Injured After Taking Recalled Cetirizine Tablets? Parker Waichman LLP Can Help.

Consumers trust that prescription and over-the-counter medications have been manufactured safely and accurately. When contamination occurs, the consequences can include serious allergic reactions, emergency medical treatment, hospitalization, and other preventable injuries.

If you or a loved one suffered harm after taking recalled cetirizine tablets or another contaminated medication, you may have important legal rights.

Parker Waichman LLP represents individuals nationwide in pharmaceutical product liability litigation involving defective and contaminated medications. The firm offers free consultations to help injured consumers understand their legal options and determine whether they may be entitled to compensation.

Call 1-800-YOUR-LAWYER (1-800-968-7529) today for a free case evaluation. Regardless of your location or where your injury occurred, our nationwide product injury law firm is ready to assist you.